NetraMark Holdings Inc. (TSX:AIAI)
0.4900
-0.0600 (-10.91%)
Nov 19, 2026, 4:00 PM EST
NetraMark Holdings Revenue
NetraMark Holdings had revenue of 430.13K CAD in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 605.97K, up 21.86% year-over-year. In the fiscal year ending September 30, 2025, NetraMark Holdings had annual revenue of 432.50K, down -5.18%. That makes NetraMark Holdings the 44,732nd largest company in the world by revenue and 966th in Canada.
Revenue (ttm)
605.97K
Revenue Growth
+21.86%
P/S Ratio
76.52
Revenue / Employee
n/a
Employees
n/a
Market Cap
46.37M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 432.50K | -23.63K | -5.18% |
| Sep 30, 2024 | 456.13K | 366.86K | 410.97% |
| Sep 30, 2023 | 89.27K | -23.76K | -21.02% |
| Sep 30, 2022 | 113.03K | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Victory Square Technologies | 78.43M |
| Hydreight Technologies | 78.43M |
| Custom Health Holdings | 44.01M |
| NexgenRx | 19.34M |
| Comprehensive Healthcare Systems | 6.20M |
| KDA Group | 419.13K |
| Principal Technologies | 370.42K |
| DIAGNOS | 65.48K |
NetraMark Holdings News
- 15 days ago - NetraMark's NetraAI Solution is Named Analytics Platform of the Year in the 2026 BioTech Breakthrough Awards - GlobeNewsWire
- 6 weeks ago - NetraMark Founder Dr. Joseph Geraci to Participate in H.C. Wainwright's AI-Based Drug Discovery and Development Conference - GlobeNewsWire
- 2 months ago - NetraMark Holdings Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 2 months ago - Peer-Reviewed Study Published in MDPI's AI Journal Shows NetraAI Uncovers Clinical Trial Signals Missed by Conventional AI and Foundation Models - GlobeNewsWire
- 2 months ago - NetraMark Appoints Former Global Atlantic Investment Office President and Scotiabank U.S. CEO Kevin Felix as Strategic Advisor - GlobeNewsWire
- 2 months ago - NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier - GlobeNewsWire
- 2 months ago - NetraMark to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - NetraMark Corporate Update Highlights Record C$3.4 Million in Fiscal 2026 Contract Bookings, Up 645% from Previous Annual High - GlobeNewsWire